CARLSBAD, Calif. and SANTIAGO, Chile, Nov. 23, 2015 /PRNewswire/ -- Biolatam® international life science partnering conference took place in Santiago, Chile, November 16–17 with great success. The event, produced by EBD Group and ASEBIO in collaboration with ProChile and Chile Biotech, was attended by over 340 life science dealmakers from pharma, biotech and service companies representing US, Latin American and European entities.
Biotech companies in attendance ranged in speciality area including health, biofuels, cosmetics, agrifood, and mining, and emerging medical technology companies. Also represented were established large medtech companies; venture capital, private equity, institutional firms and business angels; distributors and hospitals.
"We are pleased by the success of this second edition of Biolatam," said Anna Chrisman, Group Managing Director, EBD Group. "The energy was palpable, and innumerable connections were made to propel the market, both through partnering and through networking in the exhibition and evening event. Latin America is definitely a thriving emerging market that is only expected to grow."
"We have received many congratulations for this event, with a great interest of all participants, confirming the success of Biolatam as Latin America's leading biotechnology event," said Regina Revilla, Chair of ASEBIO.
Across Latin America, healthcare spending is projected to increase an average of 4.6 percent annually over 2014–2018, according to a recent Deloitte report, with pharmaceutical spending growth expected to rise an average of 6.1 percent annually. This is evidence of a growing emerging life science market, ripe for dealmaking with international companies who are actively seeking a presence in the region. Biolatam was created to foster these partnerships through dedicated one-to-one meetings facilitated by partneringONE® that could result in collaborations between companies that will fuel future growth.
The highly anticipated third edition of Biolatam will take place in San Juan, Puerto Rico, November 29–30, 2016.
Additional links and information:
Follow Biolatam 2015 on Twitter: @EBDGroup (hashtag: #BLT15) and @BIOLATAM.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group's conferences are run with the support of leading corporations and international trade associations and include:
EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
The Spanish Bioindustry Association (ASEBIO), brings together 280 companies, associations, foundations, universities, research and technology centers that carry out activities directly or indirectly related to biotechnology in Spain.
Since 1999 ASEBIO has been acting as a meeting and promotion platform for those organizations interested in stimulating the national biotechnology scene.
In order to do this, ASEBIO works closely with regional, national and European governments as well as all the social organizations interested in using biotechnology to improve quality of life, the environment and generating skilled employment. ASEBIO, ranking fourth in Europe by number of members, is part of and supported by Europabio, the European Association for Bioindustries. ASEBIO is also the organizer of Biospain. (www.biospain2016.org).
For more information please visit: www.asebio.com
SOURCE EBD Group